Rapport Therapeutics, Inc. (NASDAQ:RAPP – Get Free Report) CEO Abraham Ceesay sold 5,833 shares of the stock in a transaction that occurred on Wednesday, December 17th. The shares were sold at an average price of $29.64, for a total transaction of $172,890.12. Following the transaction, the chief executive officer owned 567,913 shares in the company, […]

Stoke Therapeutics, Inc. (NASDAQ:STOK – Get Free Report) General Counsel Jonathan Allan sold 8,785 shares of the business’s stock in a transaction dated Friday, December 5th. The shares were sold at an average price of $31.29, for a total transaction of $274,882.65. Following the completion of the sale, the general counsel directly owned 15,809 shares […]

Corcept Therapeutics Incorporated (NASDAQ:CORT – Get Free Report) insider Joseph Douglas Lyon sold 5,000 shares of the company’s stock in a transaction that occurred on Monday, December 1st. The shares were sold at an average price of $79.53, for a total transaction of $397,650.00. Following the completion of the transaction, the insider owned 10,277 shares […]